Scilex Holding Company (SCLX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 7.47 |
| Open | 7.22 |
| Day High | 7.32 |
| Day Low | 6.79 |
| 52-Week High | 21.34 |
| 52-Week Low | 2.62 |
| Volume | 70,681 |
| Average Volume | 134,545 |
| Market Cap | 58.34M |
| PE | -0.17 |
| EPS | -40.5 |
| Moving Average 50 Days | 4.79 |
| Moving Average 200 Days | 7.96 |
| Change | -0.6 |
Scilex Holding Company Announces $20 Million Strategic Investment in Quantum Scan Holdings, Inc., Targeting Trillion-Dollar Preventive Diagnosis and Prognosis Markets
GlobeNewswire Inc.
Jan 30, 2026 2:00 PM GMT
PALO ALTO, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management product
Scilex Holding Company Appoints Kasowitz LLP as Litigation and Intellectual Property Counsel
GlobeNewswire Inc.
Jan 02, 2026 2:00 PM GMT
PALO ALTO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management product
Scilex Holding Company Confirms Dream Bowl 2026 Meme Coin Claim Process on December 24, 2025 Drop by Datavault AI Inc.
GlobeNewswire Inc.
Dec 23, 2025 2:00 PM GMT
PALO ALTO, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management product